Hepatobiliary dysfunction as initial manifestation of disseminated cryptococcosis

Indian Journal of Gastroenterology

Volumn 23, Issue 4, 2004, Pages 145-146

  Kothari, Ankur A ^a,b   Kothari, Komal A ^a  

^a Baroda Medical College   (India)

^b A/7 Revapark Society   (India)

Author keywords

Obstructive jaundice

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE;

ADULT; ARTICLE; BILIARY TRACT DISEASE; BILIARY TRACT DRAINAGE; CASE REPORT; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DISEASE ASSOCIATION; HEPATOBILIARY DISEASE; HUMAN; KLATSKIN TUMOR; LIVER DISEASE; MALE; NONHUMAN; OBSTRUCTIVE JAUNDICE; RADIODIAGNOSIS;

ADULT; ANTIFUNGAL AGENTS; CHOLECYSTITIS; CHOLESTASIS; COMBINED MODALITY THERAPY; CRYPTOCOCCOSIS; DIAGNOSIS, DIFFERENTIAL; DRAINAGE; FOLLOW-UP STUDIES; FUNGEMIA; HIV SERONEGATIVITY; HUMANS; IMMUNOCOMPETENCE; LIVER; LIVER FUNCTION TESTS; MALE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 4344643669     PISSN: 02548860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Lin JI, Kabir MA, Tseng HC, Hillman N, Moezzi J, Gopalswamy N. Hepatobiliary dysfunction as the initial manifestation of disseminated cryptococcosis. J Clin Gastroenterol 1999;28:273-5.
2. Saag MS, Graybill RJ, Larsen RA, Saag MS, Pappas PG, Perfect JR, Powderly WG, et al. Practice guidelines for the management of cryptococcal disease. Clin Infect Dis 2000;30:710-8.
3. Lewis JL, Rabinovich S. The wide spectrum of cryptococcal infections. Am J Med 1972;53:315-22.
4. Klepser ME, Wolfe EJ, Pfaller MA. Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B against Cryptococcus neoformans. J Antimicrob Chemother 1998;41:397-401.